Skip to main content
. 2018 May 18;6:38. doi: 10.1186/s40425-018-0345-7

Fig. 3.

Fig. 3

Recurrence patterns among retrospective stage III cohort stratified by vaccine versus no adjuvant therapy (left, p = 0.5) indicating the number of patients with resectable versus non-resectable recurrences, and specific sites of disease recurrence among the stage III adjuvant NY-ESO1 vaccine cohort (right, n = 35)